CPhI Worldwide, organized by UBM (part of Informa PLC), has announced the finalists of the eagerly anticipated 2018 CPhI Pharma Awards.
This year’s edition features a record breaking number of entries, with over 250 from 174 participating companies across 17 categories, commending the innovations, technologies, and strategies driving pharma forward.
Such was the high caliber of entrants, 139 have been shortlisted, with the winners due to be announced during a live awards ceremony taking place at the luxurious Eurostars Madrid Tower Hotel on Tuesday October 9 – the opening day of CPhI Worldwide.
Innovations across flow chemistry, single-use technologies, drug delivery devices, contract services and packaging were amongst many shortlisted, with the judges concluding this was by far the highest ever standard of entries – further cementing 2018 as the year of innovation in pharma.
The awards for “Pharma company of the year”and “CEO of the year” will again be keenly sought as over 45,000 senior executives and 2500 companies attend at this year’s CPhI Worldwide.
To see the complete list of finalists, please visit https://awards.cphi.com/finalists/. The awards will be presented at the CPhI Awards Gala with over 350 guests in attendance.
To reserve a table for the CPhI Pharma Awards Gala, please visit https://awards.cphi.com/attend-the-gala/.
Fake Weight Loss Drugs: Growing Threat to Consumer Health
October 25th 2024In this episode of the Pharmaceutical Executive podcast, UpScriptHealth's Peter Ax, Founder and CEO, and George Jones, Chief Operations Officer, discuss the issue of counterfeit weight loss drugs, the potential health risks associated with them, increasing access to legitimate weight loss medications and more.
MDMA Therapy for Mental Health Conditions: Do the Benefits Outweigh the Risks?
October 25th 2024Despite a recent FDA Complete Response Letter issued to Lykos for midomafetamine capsules for the treatment of post-traumatic stress disorder, experts believe that the future is bright for psychedelic drugs that treat mental health conditions.
The Transformative Role of Medical Information in Customer Engagement
October 3rd 2024Stacey Fung, Head of Global Medical Information at Gilead Lifesciences, delves into the evolving role of Medical Information (MI) in the pharmaceutical industry. Covering key topics like patient engagement through omnichannel strategies, combating misinformation, and leveraging AI to enhance medical inquiries, the conversation with Stacey highlights MI's critical role in ensuring patient safety and supporting drug development. She also shares her professional journey and tidbits for early career professionals on professional development.
The Impact of Artificial Intelligence on the Creation of Medicines
October 24th 2024Najat Khan, chief R&D officer, chief commercial officer, Recursion, and Fred Hassan, director, Warburg Pincus, discuss how artificial intelligence can help reduce healthcare costs at the 20th Annual Young & Partners Pharmaceutical Executive Summit held at the Yale Club of New York.